PUBLICATIONS · 38319800
Abiraterone and Olaparib for Metastatic Castration-Resistant Prostate Cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- NEJM Evid
- Publication date
- 2022 Sep
- First author
- Clarke NW
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Clarke NW
- type
- Author
- name
- Armstrong AJ
- type
- Author
- name
- Thiery-Vuillemin A
- type
- Author
- name
- Oya M
- type
- Author
- name
- Shore N
- type
- Author
- name
- Loredo E
- type
- Author
- name
- Procopio G
- type
- Author
- name
- de Menezes J
- type
- Author
- name
- Girotto G
- type
- Author
- name
- Arslan C
- type
- Author
- name
- Mehra N
- type
- Author
- name
- Parnis F
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Clarke NW
- type
- Author
- name
- Armstrong AJ
- type
- Author
- name
- Thiery-Vuillemin A
- type
- Author
- name
- Oya M
- type
- Author
- name
- Shore N
- type
- Author
- name
- Loredo E
- type
- Author
- name
- Procopio G
- type
- Author
- name
- de Menezes J
- type
- Author
- name
- Girotto G
- type
- Author
- name
- Arslan C
- type
- Author
- name
- Mehra N
- type
- Author
- name
- Parnis F
- type
- Author
- bibliography ids
- nci-bib-825796b7cc42ee12104cc5f7
- book metadata
- content sha256
- ed55d77ce30ad04a675b0774e9129dd19fdec4147097063055ada79b3bd751ee
- document type
- citation
- dois
- 10.1056/EVIDoa2200043
- electronic publication date
- display
- 2022 Jun 3
- precision
- day
- year
- 2022
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:38319800
- immutable id
- pubmed:38319800@ed55d77ce30ad04a675b0774e9129dd19fdec4147097063055ada79b3bd751ee
- journal
- abbreviation
- NEJM Evid
- issn electronic
- 2766-5526
- issn print
- Source null
- issue
- 9
- name
- NEJM evidence
- nlm unique id
- 9918317485806676
- pages
- EVIDoa2200043
- volume
- 1
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 38319800
- provenance
- batch id
- 6d213eecf21b6b7867cb
- provider
- NCBI PubMed ESummary
- record sha256
- 1a3c5b326362f4c47123b1d7d6135ce4e64bc6426f4ca7d53c67db88197f0756
- response sha256
- 684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
- retrieved at
- 2026-09-09T23:48:19.049083+00:00
- publication date
- display
- 2022 Sep
- precision
- month
- year
- 2022
- publication types
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Abiraterone and Olaparib for Metastatic Castration-Resistant Prostate Cancer.
Preserved source evidence · Not medical advice
Triangle